Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Curanex shares rose after a cancer cachexia patient showed improvements.
Shares of Curanex Pharmaceuticals rose Monday after a patient case study showed improvements in energy and lab markers for Phyto-N, a compound under development for cancer cachexia.
The patient, a dosimetrist with a pancreatic tumor, experienced notable changes within a month.
The company emphasized the potential of this unmet medical need and is advancing Phyto-N through preclinical work.
3 Articles
Las acciones de Curanex aumentaron después de que un paciente de caquexia por cáncer mostrara mejoras.